First published online 23 October 2008
doi: 10.1242/dev.025767
Development 135, 3871-3879 (2008)
Published by The Company of Biologists 2008
Wnt5a regulates directional cell migration and cell proliferation via Ror2-mediated noncanonical pathway in mammalian palate development
Fenglei He1,2,
Wei Xiong1,2,
Xueyan Yu2,
Ramon Espinoza-Lewis1,2,
Chao Liu1,2,
Shuping Gu2,
Michiru Nishita3,
Kentaro Suzuki4,
Gen Yamada4,
Yasuhiro Minami3 and
YiPing Chen1,2,*
1 Department of Cell and Molecular Biology, Tulane University, New Orleans, LA
70118, USA.
2 Section of Oral Biology, The Ohio State University College of Dentistry,
Columbus, OH 43210, USA.
3 Department of Physiology and Cell Biology, Faculty of Medical Sciences, Kobe
University, Graduate School of Medicine, 7-5-1, Kusunoki-cho, Chuo-ku, Kobe
650-0017, Japan.
4 Center for Animal Resources and Development, Kumamoto University, Honjo 2-2-1,
Kumamoto 860-0811, Japan.
*
Author for correspondence (e-mail:
ychen{at}tulane.edu)
Accepted 7 October 2008
 |
SUMMARY
|
|---|
Tissue and molecular heterogeneities are present in the developing
secondary palate along the anteroposterior (AP) axis in mice. Here, we show
that Wnt5a and its receptor Ror2 are expressed in a graded manner along the AP
axis of the palate. Wnt5a deficiency leads to a complete cleft of the
secondary palate, which exhibits distinct phenotypic alterations at
histological, cellular and molecular levels in the anterior and posterior
regions of the palate. We demonstrate that there is directional cell migration
within the developing palate. In the absence of Wnt5a, this
directional cell migration does not occur. Genetic studies and in vitro organ
culture assays further demonstrate a role for Ror2 in mediating Wnt5a
signaling in the regulation of cell proliferation and migration during palate
development. Our results reveal distinct regulatory roles for Wnt5a in gene
expression and cell proliferation along the AP axis of the developing palate,
and an essential role for Wnt5a in the regulation of directional cell
migration.
Key words: Wnt5a, Ror2, Palatogenesis, Cleft palate, Non-canonical Wnt pathway, Cell migration
 |
INTRODUCTION
|
|---|
Cleft palate is a congenital disorder arising from a failure in the highly
regulated multiple-step process of the secondary palate development. In mice,
the palatal shelves arise from the outgrowing maxillary prominences at
embryonic day 11.5 (E11.5), and then grow vertically down on the side of the
tongue (E12.5-E13.5), followed by rapid elevation to a horizontal position
around E14.0. Subsequently, two palatal shelves meet at midline and fuse to
establish the mesenchymal continuity of the definitive palate. Recent studies
have demonstrated that the developing palate is not a homogeneous organ
(Hilliard et al., 2005
;
Okano et al., 2006
;
Gritli-Linde, 2007
). Many
genes involved in palate development exhibit regional differential expression
along the anteroposterior (AP) axis. The anterior and posterior palatal
mesenchyme also shows different molecular and cellular responses to growth
factors. This tissue and molecular heterogeneity could lead to differential
cell behaviors, such as cell proliferation, production of different
extracellular matrix and cell migration, in the palate along the AP axis.
However, despite rapid progress in the field, the exact cellular and molecular
mechanisms that are involved in morphological changes during palate
development remain unknown.
The Wnt family genes encode a large and diverse group of signaling
molecules in the patterning, proliferation and differentiation of a variety of
organs and cell types (Cadigan and Nusse,
1997
). Wnt ligand binds to its receptor Frizzled (Fz) and Lrp5/6
to activate the canonical Wnt/β-catenin signaling pathway, or functions
through β-catenin-independent pathways, the noncanonical pathways,
including the planar cell polarity (PCP) and Wnt/Ca2+ pathways
(Veeman et al., 2003
). Wnt
ligands are typically classified into canonical and noncanonical Wnts by the
pathways they work through. Wnt5a is a representative of the noncanonical Wnt
class. One function of the noncanonical pathway is its inhibition of the
canonical Wnt signaling. In Xenopus, overexpression of Wnt5a
blocks secondary axis induction by Wnt8
(Torres et al., 1996
). In the
developing limbs, Wnt5a blocks canonical Wnt pathway by promoting degradation
of β-catenin in a GSK3-independent way
(Topol et al., 2003
).
Noncanonical Wnt signaling also regulates, via the PCP pathway, convergent
extension movement, an essential cell migration process during vertebrate
gastrulation (Mlodzik, 2002
).
Altered Wnt5a function leads to dysregulated convergent extension movement in
vertebrates (Moon et al.,
1993
; Kilian et al.,
2003
). It was recently reported that an alternative Wnt receptor,
Ror2, an orphan tyrosine kinase, mediates Wnt5a-initiated noncanonical
signaling and is required for the Wnt5a-mediated inhibition of the canonical
signaling (Oishi et al., 2003
;
Mikels and Nusse, 2006
).
Interestingly, Wnt5a is also capable of activating Wnt/β-catenin
signaling in the presence of Fz4 and Lrp5
(Mikels and Nusse, 2006
). In
addition, the orphan receptor Ryk could also bind to Wnt5a besides to other
Wnt ligands (Lu et al., 2004
;
Keeble et al., 2006
).
Wnt signaling was initially implicated in palatogenesis based on the
findings that WNT3 mutations in humans and Wnt9b targeted
inactivation in mice cause a cleft palate phenotype with an incomplete
penetrance (Niemann et al.,
2004
; Carroll et al.,
2005
). Mapping of the chromosomal translocation in individuals
with non-syndromic cleft lip and palate identified a region containing
WNT5A (Blanton et al.,
2004
). Although β-catenin expression was reported in the
developing palate (Martinez-Alvarez et
al., 2000
; Tudela et al.,
2002
; Nawshad and Hay,
2003
), specific ablation of β-catenin in the
epithelial-derived tissues by a K14-Cre transgenic allele appeared
not to affect palate formation (Huelsken
et al., 2001
).
We report here that Wnt5a and its receptors exhibit a gradient
expression along the AP axis in the developing palate, consistent with a
complete cleft palate phenotype in Wnt5a-/- mice. We
analyzed the developing palate of Wnt5a mutants at the histological,
cellular and molecular levels. We show for the first time the existence of
active directional migration of mesenchymal cells in the palate, which is
disrupted in the Wnt5a-/- palate. We further reveal a
chemotactic role for Wnt5a in the palate. Genetic studies and in vitro assays
provide evidence that Ror2 mediates Wnt5a signaling through a noncanonical
pathway to regulate cell proliferation and cell migration during
palatogenesis.
 |
MATERIALS AND METHODS
|
|---|
Animal
Wnt5a+/- (Yamaguchi
et al., 1999
), TOPGAL
(DasGupta and Fuchs, 1999
) and
Actinβ-Egfp transgenic mice were purchased from the
Jackson laboratories. Generation of Ror2 mutant mice has been
described previously (Takeuchi et al.,
2000
). The genotype of these mice were determined by PCR-based
methods as described previously (DasGupta
and Fuchs, 1999
; Yamaguchi et
al., 1999
; Takeuchi et al.,
2000
). Actinβ-Egfp mice were identified by
Egfp expression under UV light.
Histology, in situ hybridization, BrdU labeling and TUNEL assays
Mouse embryos were dissected in ice-cold PBS and fixed in 4%
paraformaldehyde (PFA)/PBS overnight at 4°C before being dehydrated
through graded ethanol and embedded in paraffin. Samples were sectioned at 10
µm for histological analysis and section in situ hybridization. Detection
of cell proliferation was performed with the bromodeoxyuridine (BrdU) labeling
and Detection Kit (Roche Diagnostics Corporation, Indianapolis), and the TUNEL
assay was performed to detect cell apoptosis, as described previously
(Zhang et al., 2002
;
Alappat et al., 2005
). For in
situ hybridization experiments, at least three samples were used for each
gene. For BrdU labeling, nine sections from three samples were counted and
applied for statistical calculation. BrdU-labeled cells were counted and
presented as percentage of total nuclei within arbitrarily defined areas, and
Student's t-test was used to determine significance of
differences.
In vitro organ culture, tissue grafting, DiI cell labeling, and bead implantation
Secondary palatal shelves were microdissected from E12.5 or E13.5 embryos,
orientated with dorsum upwards, and placed on filter in Trowell type organ
cultures, as described previously (Zhang
et al., 2002
). For in vitro palate fusion assay, paired palatal
shelves from E13.5 embryos were placed in organ culture as described
previously (Taya et al.,
1999
). Samples were harvested after 3 days in culture and
processed for histological analysis. For tissue grafting, donor palatal
mesenchyme from E12.5 Actinβ-Egfp embryos were
carefully dissected with fine forceps, minced into small tissue pieces and
implanted into the same position in explanted host palatal shelves from
aged-matched embryos. Explants were cultured in
-MEM medium plus 10%
FBS, monitored for cell migration under a fluorescence microscope at 24-hour
intervals for 72 hours. For DiI labeling experiment, the lipophilic dye DiI
(1,1-dioctadecyl-3,3,39,39-tetramethyl-indocarbocyanine perchlorate; Molecular
Probes) was initially prepared at a concentration of 0.5% in 100% ethanol and
then diluted 1:9 with 0.3 M sucrose containing 0.1% Nile Blue sulfate. The DiI
solution was injected into explanted palatal shelves using a micropipette
(Li and Muneoka, 1999
).
Protein-soaked beads were implanted to explanted palatal shelves, about
250-300 µm away from the DiI injection site. Migration of DiI-labeled cells
was monitored in a similar way for monitoring Egfp-expressing cell
migration. Bead preparation and implantation were performed as reported before
(Chen et al., 1996
;
Zhang et al., 2002
). Affi-Gel
blue agarose beads (100-200 µm in diameter, from Bio-RAD, Hercules, CA)
were used as carriers for Shh, Wnt5a and Bmp4, and heparin beads (Sigma, St
Louis, MO) were used as carriers for Fgf10. All the proteins were purchased
from R&D Systems (Minneapolis, MN).
 |
RESULTS
|
|---|
Expression of Wnt5a and its receptors in the developing palate.
The developing secondary palate displays tissue heterogeneity as well as
differential gene expression along the AP axis
(Hilliard et al., 2005
). In an
effort to identify genes that exhibit such an expression pattern in the
palate, we compared the gene expression profiles from the anterior (anterior
to the first molar) versus posterior (posterior to the first molar) region of
the E13.5 palatal shelves by Affimetrix chip microarray assays. Several genes
that encode components of Wnt signaling pathway, including Wnt5a,
frizzled 4 (Fzd4), Ror2 and β-catenin (Catnb),
showed differential expression levels between the anterior and posterior
palate, which was subsequently confirmed by in situ hybridization assays.
Wnt5a expression was detected in the palatal mesenchyme, in a graded
fashion along the AP axis (higher levels in the anterior region)
(Fig. 1A,E). A gradient
expression for Wnt5a along the nasal-oral axis was also observed
(Fig. 1A,E). Fzd4 and
Ror2 were also expressed, in a similar AP gradient fashion, in the
epithelium and mesenchyme of the palate, with a restricted mesenchymal domain
adjacent to the medial edge epithelium (MEE)
(Fig. 1B,C,F,G). A graded
expression of β-catenin, mainly in the MEE, was also detected along the
AP axis of the palate (Fig.
1D,H).
Wnt5a mutant mice exhibit complete cleft secondary palate
The expression of Wnt5a and its receptors Fzd4 and
Ror2 suggests a role for these genes in palatogenesis. The fact that
Ror2 knockout mice exhibit a cleft palate phenotype
(Schwabe et al., 2004
) and
that individuals with non-syndromic cleft lip and palate have been linked to
chromosomal translocation containing WNT5A locus
(Blanton et al., 2004
) promoted
us to examine a cleft palate phenotype in Wnt5a-/- mice.
Gross morphological and histological examinations revealed a complete cleft
palate phenotype in Wnt5a-/- mice
(Fig. 2A,B). In the mutants,
the deformed palatal shelves were distinguishable as early as E12.5 but became
pronounced by E13.5. At E13.5, when the palatal shelves in the wild type take
the vertical position on both sides of the tongue, the anterior region of the
mutant palatal shelves remained in the horizontal position
(Fig. 2C,D). By contrast, the
posterior portion of the mutant palatal shelves grew in a vertical growth
position (Fig. 2E,F).
Morphologically, the mutant anterior palatal shelf appeared round, shortened
and blunt-ended, lacking the ventrolateral indention of the shelf
(Fig. 2D), whereas the
posterior shelf was shortened, broadened and wedge-shaped
(Fig. 2F). At E14.5, the
wild-type palatal shelves have elevated to above the tongue and fused at the
midline (Fig. 2G,I). In
Wnt5a mutant, the anterior region of the palatal shelves remained in
horizontal level but was too short to make a contact
(Fig. 2H). However, the
posterior palatal shelves failed to elevate
(Fig. 2J). The lack of contact
between the palatal shelf and tongue/mandible suggests an intrinsic defect in
elevation. The gradient expression of Wnt5a along the AP axis of the
developing palate appears to account for the distinct morphological defects
found in the anterior and posterior palate of the mutant. In addition,
Wnt5a mutants also displayed a short and small tongue, and a deformed
oral cavity, which may contribute, to some extent, to the cleft palate
defect.
Wnt5a mutant exhibits an impaired palatal growth
To reveal the cellular mechanisms responsible for the palate deformation in
Wnt5a-/- mice, we carried out cell proliferation and
apoptosis assays as well as in vitro palate fusion assay. We determined cell
proliferation rate in the wild type and Wnt5a-/- palates
at E13.5 by BrdU labeling. As controls, BrdU-positive cells were also counted
in the maxillary mesenchyme lateral to the palate where Wnt5a is not
expressed. An altered cell proliferation rate was found in the mutant palatal
mesenchyme (Fig. 3).
Intriguingly, a significantly elevated cell proliferation level was seen in
the anterior palate, whereas a decreased rate occurred in the posterior
palate. This differential alteration of cell proliferation rate in the
Wnt5a-/- palate along the AP axis implicates dual roles
for Wnt5a in the regulation of cell proliferation. It is interesting to note
that, in the anterior palate of the mutant, the mesenchymal cells on the
future nasal side were much more mitotic than cells on the future oral side.
This dysregulated cell proliferation level in the future nasal aspect
apparently accounts for, at least partially, the deformed shape of the mutant
palatal shelves and a failure in change of palate growth direction from the
horizontal to vertical position. However, TUNEL assays revealed a comparable
level of cell apoptosis in the wild-type and Wnt5a-/-
palatal shelves at E13.5 (data not shown). To determine whether the formation
of a cleft palate in Wnt5a mutants could also be attributed to a
failure in palate fusion, we employed an in vitro organ culture system to
examine palate fusion. The results demonstrated that pairs of palatal shelves
from E13.5 Wnt5a-/- embryos, when placed in contact with
the MEE and facing one another, were able to fuse, in a way identically to the
wild-type controls (data not shown). The dysregulated cell proliferation in
the palatal mesenchyme therefore represents a major cellular process that
causes a cleft palate formation in Wnt5a mutants.

View larger version (50K):
[in this window]
[in a new window]
|
Fig. 1. Differential gene expression along the AP axis of E13.5 palatal
shelf. (A,E) Gradient Wnt5a expression is detected
in palatal mesenchyme, higher in the anterior (A), and lower in the posterior
(E) domain. (B,F) Fz4 expression is detected in the
anterior palate (B), but not in the posterior region (F). (C,G)
Ror2 exhibits a gradient expression, with higher level in the
anterior palate (C) and lower in the posterior region (G). (D,H)
Gradient Catnb expression is detected in the developing palate,
higher in the anterior (D), while lower in the posterior (H) palate. There is
strong Catnb expression in the MEE (arrow) of the anterior palate. T,
tongue; PS, palatal shelf.
|
|

View larger version (97K):
[in this window]
[in a new window]
|
Fig. 2. Cleft palate phenotype in Wnt5a mutant. (A) An E18.5
wild-type mouse shows an intact palate. (B) An E18.5 Wnt5a
mutant shows wide open cleft secondary palate. (C,E) Coronal
sections of an E13.5 control embryo show the normal palatal shelves at the
anterior (C) and posterior domain (E). Arrows in C indicate the ventrolateral
indention. (D) A coronal section of an E13.5 Wnt5a mutant
shows the palatal shelves in the horizontal level lacking the ventrolateral
indention (arrows). (F) The posterior palatal shelves of an E13.5
mutant exhibit an abnormal shape. (G,I) An E14.5 control embryo
shows closure of the palate at the anterior (G) and posterior region (I).
(H) The anterior palatal shelves of an E14.5 Wnt5a mutant
remain at the horizontal level but appear too short to make contact at the
midline. (J) The posterior palate of an E14.5 mutant fails to elevate,
remaining at the vertical position. T, tongue; PS, palatal shelf.
|
|
Altered gene expression in the Wnt5a-/- palate
We next examined the expression of a number of genes in the palatal shelves
of Wnt5a mutants. They are either potential Wnt5a downstream
genes or genes that exhibit an overlapped expression domain in the palate with
Wnt5a, including Shh, Ptch1, Bmp4, Bmp2, Msx1, Fgf10, Fgfr2,
Shox2 and Sox9. In E13.5 Wnt5a mutants, Bmp4
was downregulated in the anterior palate
(Fig. 4C,D), but displayed an
ectopic expression domain in the posterior palatal mesenchyme on the nasal
side, where Bmp4 is not normally expressed
(Fig. 4G,H). Consistent with
the fact that mesenchymally expressed Bmp4 positively regulates Shh
in the palatal epithelium (Zhang et al.,
2002
), Shh in the MEE of the anterior palate was
downregulated (Fig. 4A,B),
whereas an ectopic Shh expression was observed in the nasal side
epithelium of the posterior palate, immediately adjacent to the ectopically
expressed Bmp4 domain in the palatal mesenchyme
(Fig. 4F,H). Ptch1, a
downstream target and receptor of Shh, displayed altered expression pattern
accordingly along the AP axis (Fig.
4I,J,M,N). However, as the mutant palatal shelves are so
malformed, the exact position where Shh is ectopically activated in
the palate remains to be determined. Nevertheless, these observations place
Wnt5a upstream of Shh and Bmp4, consistent with the
previous report in the developing lung (Li et al.,
2002
;
2005
). Msx1, a
downstream target of Bmp4, was partially downregulated in the
anterior palatal mesenchyme of the Wnt5a-/- palate
(Fig. 4K,
Fig. 5L). Although the
expression of Bmp2, a downstream target of Shh that mediates
the mitotic effect of Shh in the anterior palate
(Zhang et al., 2002
), remained
unchanged in the anterior palate of the mutant (data not shown), a significant
downregulation of Bmp2 was observed in the posterior palatal
mesenchyme (Fig. 4O,P). It
appears that other upstream factors besides Shh are also involved in
regulating Bmp2 expression. By contrast, Fgf10 and its
receptor Fgfr2 exhibited comparable expression level and pattern in
both wild-type and mutant palate (data not shown). These results demonstrate
that Wnt5a acts differentially, in term of gene expression
regulation, in the anterior and posterior palate.

View larger version (54K):
[in this window]
[in a new window]
|
Fig. 3. BrdU labeling of cells in the developing palate. (A-D)
Coronal sections through the anterior (A,B) and posterior (C,D) palates of an
E13.5 wild-type control (A,C) and an E13.5 Wnt5a mutant (B,D) showing
BrdU-labeled cells. Boxes in each panel indicate the area where the labeled
cells were counted and compared. (E) Comparison of percentage of
BrdU-labeled cells in the fixed areas of the palate in the wild-type control
and mutant embryos. Standard deviation values are indicated as the error bars.
*P<0.05.
|
|

View larger version (127K):
[in this window]
[in a new window]
|
Fig. 4. Gene expression in E13.5 wild-type and Wnt5a-/-
palate. (A) The anterior palate of a wild-type embryo shows
Shh expression in the MEE (arrow) and rugal epithelium. (B)
Shh expression becomes undetectable in the MEE but remains in the
rugal epithelium (arrow) in the anterior palate of a Wnt5a mutant.
(C,D) Bmp4 expression is detected in the anterior
palate of a wild-type control (C), but is significantly reduced in the mutant
(asterisk, D). (E,F) In the posterior palate of the control,
Shh expression is detected in the rugal epithelium at the ventral
(oral side) (E), whereas in the mutant, an ectopic Shh expression is
found in the dorsal (nasal) epithelium (arrow) of the palate (F).
(G,H) Bmp4 expression is absent in the posterior palate
of the control (G), but is found ectopically in the mesenchyme of the
posterior palate on the future nasal side (arrow) in the mutant (H).
(I) Ptch1 expression is seen in the anterior palate of the
control, mainly in the ventral (oral) side. (J) A downregulated
Ptch1 is seen in the anterior palate of a Wnt5a mutant.
(K,L) Msx1 expression is detected in the anterior
palatal mesenchyme of a wild-type control (K), but is downregulated in the
palatal mesenchyme (asterisk) adjacent to the MEE at the similar level of a
mutant palate (L). (M,N) Ectopic Ptch1 expression is
found in the dorsal (nasal) aspect (arrow) of the palate in the posterior
region in a Wnt5a mutant (N), when compared with its normal
expression in the control (M). (O,P) A downregulation of
Bmp2 expression is found in the posterior palate of Wnt5a
mutant (P), when compared with its normal expression pattern in the control
(O). (Q) Sox9 expression in the anterior palatal mesenchyme of
a control embryo. (R) A shifted Sox9 expression domain is seen
in the anterior palate of a Wnt5a mutant. Broken lines in Q,R
indicate the expression boundary. (S,T) Shox2
expression remains in the anterior palate of the mutant (T), when compared
with that in the control (S). T, tongue; PS, palatal shelf; MNP, medial nasal
process.
|
|
Wnt5a and Ror2 exert an epistatic effect on palate development
As cell proliferation was increased in the anterior palatal mesenchyme
lacking Wnt5a and as the canonical Wnt signaling is known to control
proliferation, it is possible that Wnt5a normally antagonizes the canonical
pathway in the developing palate. To determine this possibility, we examined
the expression of TOPGAL, a transgenic reporter of activation of the canonical
Wnt signaling pathway, in the wild type and Wnt5a-/-
background (DasGupta and Fuchs,
1999
). We failed to detect TOPGAL expression in the developing
palate of both wild type and Wnt5a mutants (data not shown),
suggesting that the canonical Wnt signaling pathway may not be involved in
palate development. The fact that mice lacking Fz4, the receptor that is
expressed in the developing palate and mediates the canonical signaling of
Wnt5a, survive to adulthood without a defective palate
(Hsieh et al., 2005
), implies
an involvement of noncanonical pathway. The fact that both
Ror2-/- and Wnt5a-/- mice exhibit a
cleft palate phenotype strongly implicates an overlapping role for these two
molecules. We therefore examined the cleft palate defect in
Ror2-/- embryos. Similar to Wnt5a mutant, we
found a downregulated Shh in the MEE and an enhanced cell
proliferation rate in the anterior palatal mesenchyme of
Ror2-/- embryos (Fig.
5). We subsequently tested a genetic interaction between
Wnt5a and Ror2 by compounding Wnt5a+/-
and Ror2+/- to generate double heterozygous mice.
Wnt5a+/-;Ror2+/- mice indeed exhibited
cleft palate defects that phenocopy that of Ror2-/-
mutants, including downregulated Shh expression in the MEE and
upregulated cell proliferation rate in the mesenchyme of the anterior palate,
particularly in the nasal aspect (Fig.
5). These results demonstrate an epistatic effect of these two
genes on palate development. However, the posterior palatal shelves of
Ror2-/- and
Wnt5a+/-;Ror2+/- mice did not show an
altered cell proliferation rate, consistent with an extremely low level of
Ror2 expression in this region. As the palatal phenotypes in
Ror2-/- and
Ror2+/-;Wnt5a+/- mice appear milder
when compared with that of Wnt5a mutants, Ror2 is not the
only receptor mediating the function of Wnt5a during palatogenesis.

View larger version (107K):
[in this window]
[in a new window]
|
Fig. 5. Wnt5a and Ror2 have an epistatic effect on palate
development. (A) An E14.5 wild-type embryo shows the closure of the
palate. (B) An E14.5 Ror2-/- embryo shows a failed
palatal elevation. (C) Failed palatal elevation is observed in an E14.5
Ror2+/-;Wnt5a+/- embryo. (D-F)
Sections through the anterior palate of E13.5 wild-type control (D),
Ror2 mutant (E) and
Ror2+/-;Wnt5a+/- embryo (F) show
Shh expression in the MEE of the control palate, but a lack of
Shh expression in the MEE of the Ror2-/- and
Ror2+/-;Wnt5a+/- palate. Arrows
indicate the MEE. (G) The anterior palate of an E13.5 control embryo
shows BrdU-labeled cells. (H,I) The level of cell proliferation
is similarly increased in the anterior palate of Ror2-/-
(H) and Ror2+/-;Wnt5a+/- (I) embryos.
The red lines in G-I separate the dorsal and ventral halves of the palate. T,
tongue; PS, palatal shelf.
|
|

View larger version (55K):
[in this window]
[in a new window]
|
Fig. 6. Regulation of cell proliferation in palatal mesenchyme by Wnt5a is
mediated by Ror2. (A) An explanted wild-type palatal shelf
implanted with BSA bead shows BrdU-labeled cells in the distal (the MEE side)
mesenchyme. (B) An explanted wild-type palatal shelf implanted with a
Wnt5a-soaked protein shows a reduced rate of cell proliferation in the distal
mesenchyme. (C) A higher cell proliferation rate is seen in an
explanted Wnt5a-/- palatal shelf implanted with a BSA
bead. (D) Cell proliferation rate is rescued to about the normal level
in an explanted Wnt5a-/- palate by a Wnt5a-soaked bead.
(E,F) Elevated cell proliferation rate is seen in an explanted
Ror2-/- palatal shelf implanted with a BSA bead (E), and
remains in an explanted Ror2-/- palatal shelf implanted
with a Wnt5a bead (F). (G) Comparison of percentage of BrdU-labeled
cells in the fixed area (box) of the palate of different genotypes implanted
with BSA- or Wnt5a-soaked beads. Standard deviation values were indicated as
the error bars. B, bead. In all images, the MEE is towards the left.
*P<0.01.
|
|
We further confirm a role for Ror2 in mediating Wnt5a signaling in the
regulation of cell proliferation by bead implantation experiments. Beads
soaked with BSA (1 mg/ml) or Wnt5a (0.5 mg/ml) were implanted, respectively,
onto explanted anterior palatal tissues from E13.5 wild-type,
Wnt5a-/- and Ror2-/- embryos. Samples
were cultured for 24 hours and pulsed with BrdU prior to fixation. Consistent
with the results by in vivo BrdU labeling assays, elevated cell proliferation
levels were observed in the Wnt5a-/- and
Ror2-/- palatal tissues implanted with BSA beads, when
compared with that in the wild-type controls
(Fig. 6A,C,E). A significantly
decreased rate of cell proliferation was seen in the wild-type palatal tissues
implanted with Wnt5a beads (Fig.
6B,
6G), indicating that overdosed
exogenous Wnt5a protein represses cell proliferation. Furthermore, a
dramatically reduced level of cell proliferation was found in the
Wnt5a-/- palate implanted with Wnt5a bead
(Fig. 6B,D,G), demonstrating a
rescue of the altered cell proliferation phenotype in the mutants. By
contrast, Wnt5a beads failed to rescue cell proliferation defect in the
Ror2-/- palatal tissues
(Fig. 6F,G).
Wnt5a-deficiency leads to altered cell migration in the palatal mesenchyme
In the assays for gene expression, we made an interesting observation about
Sox9 expression, a HMG box gene whose mutation also leads to cleft
palate formation (Bi et al.,
1999
; Mori-Akiyama et al.,
2003
). Sox9 is expressed and regulated by Shox2
in the anterior palatal mesenchyme (Fig.
4Q) (Yu et al.,
2005
; Gu et al.,
2008
). Consistent with an unaltered Shox2 expression
(Fig. 4S,T), Sox9
expression was maintained in the anterior palatal mesenchyme of Wnt5a
mutant (Fig. 4R). However, a
close examination identified a shifted expression domain of Sox9. In
the controls, Sox9 expression was restricted to the distal region
(the MEE side) of the anterior palate (Fig.
4Q). In the mutant, however, Sox9 expression domain was
shifted to the future nasal side (Fig.
4R), which could reflect a positional change of the
Sox9-expressing cells in the palate. Based on this assumption, we
reasoned that a constant cell migration exists in the developing palatal
mesenchyme. Aberrant cell migration could lead to a change in position of the
mesenchymal cells within the Wnt5a-/- palate.

View larger version (82K):
[in this window]
[in a new window]
|
Fig. 7. Aberrant cell migration in the Wnt5a-/- palate.
(A-A'') Egfp-expressing mesenchymal cells from the
anterior palate, when grafted to the anterior region of an explanted wild-type
palatal shelf, exhibit a directional migration towards to the lateral side
after 24 hours. Arrows indicate the migrating cells. (B-B'')
Egfp-expressing mesenchymal cells from the posterior palate, when
grafted to the posterior region of an explanted wild-type palatal shelf, show
a directional migration towards the anterior end after 24 hours.
(C-C'',D-D'') Directional migration by the
Egfp-expressing cells is not observed when these cells are grafted to
either the anterior (C-C'') or the posterior (D-D'') palatals
shelves from Wnt5a mutants.
|
|
To test these hypotheses, we first determined if constant cell migration
does exist in the developing palate. E12.5 palatal shelves were isolated and
placed with the AP axis marked in organ culture. The anterior and posterior
palatal mesenchymal tissues from E12.5 Actinβ-Egfp mice
were grafted into the explanted palatal shelves in their original positions,
respectively. Cell migration was subsequently monitored at 24-hour intervals.
As shown in Fig. 7, the
Egfp-expressing cells underwent an active cell migration within the
host tissue environment. Surprisingly, the cell migration was not random but
directional, indicating the existence of a chemoattractant gradient. When the
Egfp-expressing posterior palatal mesenchyme was grafted into the
posterior region of the host explants, they displayed a directional migration
towards the anterior side in 77% of grafts
(Fig. 7B;
Table 1). This posterior to
anterior cell migration pattern coincides with the gradient Wnt5a
expression along the AP axis. However, in the anterior palate, the grafted
anterior palatal cells exhibited a directional migration towards the lateral
side in the majority of the cases (54%)
(Fig. 7A;
Table 1). In about 13% of
cases, directional cell migration towards the medial side was recorded.
Nevertheless, these results demonstrate the existence of active directional
cell movement in the developing palate.
We next asked whether the directional cell migration could become altered
in the palatal mesenchyme lacking Wnt5a. In a similar assay using E12.5,
Wnt5a-/- palatal shelves as hosts, we did not observe a
constant directional cell migration in both the anterior and posterior palatal
regions (Table 1). In most
cases (more than 80%), the grafted cells either migrated slightly but
randomly, or never moved (Fig.
7C,D), indicating a defective cell movement in the
Wnt5a-/- palate.
Ror2 mediates the chemotactic activity of Wnt5a in the developing palate
We tried to determine whether Wnt5a acts as a chemoattractant for
mesenchymal cells of the palate. We coupled DiI-cell labeling/tissue grafting
with bead implantation in explanted palatal shelves. As shown in
Fig. 8, BSA-soaked beads (1
mg/ml) had no influence on migration direction of DiI-labeled cells or grafted
Egfp-expressing cells (26/28). By contrast, DiI-labeled cells/grafted
Egfp-expressing cells exhibited a directional migration towards
Wnt5a-soaked beads (0.5 mg/ml) in 24 hours
(Fig. 8B). This chemotactic
effect of Wnt5a was seen in 69% of cases (25/36). We also found that cells
responded to the chemotactic action of Wnt5a identically, regardless where the
beads were implanted, implying that exogenous Wnt5a has overcome the
endogenous gradient. To further test whether Wnt5a is essential and sufficient
to drive AP cell movement in the palate, we applied Wnt5a beads onto the
anterior side of E12.5 Wnt5a-/- palatal shelves in culture
and monitored the movement of DiI-labeled cells in the posterior palate. A
constant cell migration towards the anterior aspect (exogenous Wnt5a source)
was observed (6/10) (data not shown).

View larger version (78K):
[in this window]
[in a new window]
|
Fig. 8. Ror2 mediates chemotactic action of Wnt5a in the developing palate.
(A-A'') BSA bead fails to exert chemotactic effect on DiI-labeled
mesenchymal cells and grafted Egfp-expressing cells (insert in
A'). (B-B'') Wnt5a acts as a potent chemoattractant to
attract DiI-labeled mesenchymal cells and grafted Egfp-expressing
cells (inserts in B', 48 hours in culture). Arrows indicate DiI-labeled
cells attracted to Wnt5a bead. (C-C'') Few DiI-labeled cells
(arrows) are attracted to Wnt5a bead in an explanted palatal shelf from
Ror2-/- embryo. (D-D'') Fgf10 acts as a
chemoattractant for palatal mesenchymal cells. Heparin beads were used for
Fgf10 soaking, which is invisible under UV light, and are outlined by the
broken line. B, bead.
|
|
It has previously been reported that Ror2 is required for Wnt5a-induced
cell migration (Nishita et al.,
2006
; Yamamoto et al.,
2007
). To determine whether Ror2 also mediates the chemotactic
activity of Wnt5a in the developing palate, we performed DiI labeling and bead
implantation on the explanted palatal shelves from E12.5
Ror2-/- embryos. As expected, Wnt5a beads did not exhibit
a chemotactic effect on the DiI-labeled cells (9/10). Occasionally, very weak
chemotactic response was observed. A few labeled cells could be found around
the Wnt5a bead after an extended culture period
(Fig. 8C).
Several other growth factors are expressed in the anterior palate,
including Bmp4, Fgf10 and Shh (Zhang et
al., 2002
; Rice et al.,
2004
; Alappat et al.,
2005
). We wondered whether any of these factors are also
implicated in regulating cell migration. We found that Shh (0.5 mg/ml) and
Bmp4 (0.4 mg/ml) did not act either as a chemoattractant or a chemorepellent
in the palate (data not shown). By contrast, Fgf10, a known chemoattractant
for several types of cells (Park et al.,
1998
; Ceccarelli et al.,
2007
; Natanson-Yaron et al.,
2007
), exhibited a chemotactic potency for the palatal mesenchymal
cells (Fig. 8D), which was
observed in 63% of total cases (10/16).
 |
DISCUSSION
|
|---|
Cell movement is an essential process during embryogenesis and the
formation of many organs. In the developing limbs, cell migration is crucial
for pattern formation and outgrowth. Abnormal cell migration or change of
migration direction could cause dramatic changes in limb bud shape and
outgrowth inhibition (Li and Muneoka,
1999
). During palate development, palatal shelves undergo rapid
outgrowth and significant changes in palate shape and position. Cell
proliferation and extracellular matrix production and deposition within the
palatal mesenchyme contribute to these processes significantly
(Ferguson, 1988
;
Gritli-Linde, 2007
). The
morphological movement of the palatal shelf has been considered an active
process of shelf elevation. However, an active directional cell migration by
the mesenchymal cells during palate development has not been reported. In this
paper, we demonstrate the existence of two streams of active directional cell
migration: in the posterior palate, cells migrate towards to anterior aspect,
whereas in the anterior palate, cells move towards the lateral aspect. Though
its biological significance in palate formation is yet to be elucidated, the
directional cell migration should have a crucial role in palate patterning
(shaping) and elevation. The Wnt5a-/- deformed palate
could be partially attributed to the aberrant cell migration. During palate
shelf elevation, different means (rotation versus remodeling) are thought to
be used in different regions of the palate along the AP axis
(Okano et al., 2006
). The
distinct directions of cell migration in the anterior and posterior palate may
represent a cellular process underlying these two different elevation
mechanisms. Computer modeling studies will be required to model cell migration
directionality associated with palate elevation.
Wnt5a has been implicated in cell migration in developing vertebrate
embryos and in invasive cancer cells
(Weeraratna et al., 2002
;
Jopling and den Hertog, 2005
;
Kim et al., 2005
;
Witze et al., 2008
). Here, we
show a defective cell migration in the Wnt5a-/- palate.
Our results prove that Wnt5a is a potent and specific chemoattractant for the
palatal mesenchymal cells. The gradient of Wnt5a expression along the
AP axis therefore sets a chemotactic base for the posterior-to-anterior
migration of the mesenchymal cells in the palate. Such graded expression was
also observed for Wnt5a in those organs and tissues that undergo outgrowth,
including the limb and tailbud (Yamaguchi
et al., 1999
). Consistent with the graded fashion of
Wnt5a expression in the distal limb mesenchyme, active
proximal-distal cell migration has been reported in developing chick limb buds
(Li and Muneoka, 1999
).
Although defective cell migration has not yet been reported in the limbs of
mice lacking Wnt5a, a reduced Wnt5a dose indeed impairs cell
migration in fish fins, the homolog of the tetrapod limbs (Sakahuchi et al.,
2006). In addition, impaired cell migration has been reported in the
developing pancreas of Wnt5a-/- embryo
(Kim et al., 2005
). In the
developing palate, Ror2 appears to be essential for the chemotactic action of
Wnt5a, as cells lacking Ror2 failed to respond to Wnt5a. It has been
shown that Ror2 is required for Wnt5a-induced migration of cultured cells by
mediating filopodia formation (Nishita et
al., 2006
). By contrast, it has recently been shown that Wnt5a can
also act as a chemorepellent for neuronal cells
(Keeble et al., 2006
). This
chemorepulsive action of Wnt5a is mediated by Ryk. Wnt5a thus has dual roles
in the regulation of cell migration, depending on the presence of specific
receptor. As Ryk is also expressed in the developing palate in a
punctuate pattern (Halford et al.,
2000
), the Ryk-expressing cells could move in a direction
away from the source of Wnt5a. This potential chemorepulsive action of Wnt5a
may account partially for the lateral directionality of mesenchymal cells
migration in the anterior palate, which warrants future investigation.
Many growth factors and receptors are expressed in a specific temporal and
spatial manner in the developing palate
(Gritli-Linde, 2007
). Of them,
some are proven chemoattractants. We demonstrate in this study that, besides
Wnt5a, Fgf10 is also a potent chemoattractant for mesenchymal cells of the
palate. Fgf10 is expressed in the lateral region of the anterior
palate at E12.5 and E13.5 (Alappat et al.,
2005
), which could at least partially account for the lateral
migration of mesenchymal cells. As the primary Fgf10 receptor Fgfr2b is only
expressed in the palatal epithelium (Rice
et al., 2004
), this chemotactic action of Fgf10 is probably
mediated by other Fgf receptor(s) in the mesenchyme. This idea is supported by
the fact that exogenous Fgf10 inhibits cell proliferation in the anterior
palatal mesenchyme (Yu et al.,
2005
). As multiple chemoattractants and chemorepellents are likely
to be present in the developing palate, the directionality of cell migration
is probably controlled by a combinatorial effect of multiple factors.
The gradient expression of Wnt5a and its receptors Fz4
and Ror2 correlates with the tissue heterogeneity along the AP axis
of the developing palate. We observed in the Wnt5a-/-
palate altered expression of several genes crucial for palate development.
However, a closer examination of gene expression reveals distinct or even
opposite responses of the anterior and posterior palatal tissues to the
absence of Wnt5a. For example, Shh and Bmp4 were
downregulated in the anterior palate, but were ectopically activated in the
posterior region. In addition, opposite cellular responses (cell
proliferation) were found in the anterior and posterior palatal mesenchyme
lacking Wnt5a, with an increased level of cell proliferation in the
anterior but a decreased level in the posterior palate. Shh has been shown to
positively regulate cell proliferation in the palatal mesenchyme
(Zhang et al., 2002
). However,
the altered Shh expression patterns do not correlate with the changes
in cell proliferation rate in the Wnt5a-/- palate. One
would expect a decreased cell proliferation rate in the anterior region of the
Wnt5a-/- palate where Shh is downregulated.
However, a hyperproliferation of mesenchymal cells was instead observed,
suggesting an involvement of multiple signaling pathways in cell proliferation
regulation in the anterior palate where Wnt5a-mediated signaling acts as a
negative regulator. By contrast, the proliferation rate in the posterior
palate of Wnt5a mutant is significantly decreased when compared with
the controls, revealing a positive role for Wnt5a in cell proliferation
regulating in the posterior palate. As the number of migrating mesenchymal
cells in the palate appears small, the altered expression of these crucial
morphogenetic genes and the aberrant cell proliferation appear to have major
impact on cleft palate formation in Wnt5a mutants.
Wnt5a has been previously shown to exert distinct effects on cell
proliferation in different developing organs. Inactivation of Wnt5a
results in reduced proliferation rate of the progenitor cells in the
developing limbs, but leads to an increased level of cell proliferation during
distal lung morphogenesis and mammary tissues
(Yamaguchi et al., 1999
;
Li et al., 2002
;
Li et al., 2005
;
Roarty and Serra, 2007
). Wnt5a
has also been shown to inhibit B cell proliferation and functions as a tumor
suppressor in hematopoietic tissue (Liang
et al., 2003
). However, in the developing palate, Wnt5a appears to
exert opposite roles in the regulation of gene expression and cell
proliferation in different regions. The differential expression of Wnt5a
receptors (such as Ror2 and Fz4) in the palatal shelf along the AP axis could
account for the distinct functions of Wnt5a. It is possible that other
unidentified Wnt5a receptors are expressed and involved in mediating Wnt5a
signaling in the palate. However, several signaling pathways initiated by
other growth factors, including BMP, FGF and TGFβ, have been proven to
differentially operate and exert their distinct effects on cell proliferation
regulation in different domains of the developing palate along the AP axis. A
combinatorial effect of, and a finely tuned balance between, these signaling
pathways appear essential for the precise control of normal palate growth. The
absence of Wnt5a could disrupt the closely linked signaling network,
leading to dysregulated cell proliferation rate.
Wnt5a has dual roles in signaling: activating either the Wnt canonical or
noncanonical signaling pathways. At least two known Wnt5a receptors, Fz4,
which mediates the activation of the canonical pathway by Wnt5a, and Ror2,
which mediates the noncanonical signaling, are expressed in an overlapping
pattern with Wnt5a in the developing palate. However, activities of the
canonical Wnt signaling were not detected in the developing palate in
wild-type and Wnt5a-/- mice, excluding an involvement of
the canonical Wnt signaling in palate development. However, we cannot rule out
the possibility that the TOPGAL transgenic allele is not sensitive enough to
detect a low signaling level. Wnt5a appears to regulate palatogenesis via a
noncanonical Wnt pathway that does not antagonize the canonical signaling. The
fact that Fz4-null mice do not exhibit a cleft palate defect and that
the inactivation of both Lef1 and Tcf4, the essential
nuclear mediators of the canonical Wnt signaling, does not cause an abnormal
palate formation, further supports this conclusion
(Hsieh et al., 2005
;
Brugmann et al., 2007
). Several
lines of evidence support the conclusion that Ror2 mediates the function of
Wnt5a in regulating palatogenesis: (1) Wnt5a and Ror2 are
co-expressed in the anterior palatal mesenchyme; (2) Wnt5a and
Ror2 exert an epistatic effect in palate development; (3) the similar
cleft palate phenotype, including elevated cell proliferation rate and altered
expression pattern of downstream genes, are seen in both Wnt5a and
Ror2 mutants; (4) exogenous Wnt5a protein fails to rescue (reduce)
cell proliferation rate in Ror2-/- palatal mesenchyme; (5)
exogenous Wnt5a protein fails to exert chemotactic effect on the palatal cells
lacking Ror2. In fact, Ror2-mediated Wnt5a signaling can active the
Wnt-JNK pathway and/or inhibit Wnt canonical signaling cascade
(Oishi et al., 2003
;
Mikels and Nusse, 2006
;
Schambony and Wedlich, 2007
).
Although the activity of Wnt/β-catenin canonical signaling is not
detected or elevated in Wnt5a-/- palate, it still remains
unknown whether Wnt5a/Ror2 acts through the JNK pathway to regulate
palatogenesis.
 |
ACKNOWLEDGMENTS
|
|---|
The authors thank Drs Manjong Han and Ken Muneoka for providing DiI reagent
and protocols, and Dr Philippa Francis-West for her critical reading and
suggestions on the manuscript. This work was supported by NIH grants
R01DE12329 and R01 DE14044 to Y.P.C., and by a subcontract of P50 DE16215 to
J. Murray (University of Iowa), which supported Y.P.C.
 |
REFERENCES
|
|---|
Alappat, S. R., Zhang, Z., Suzuki, K., Zhang, X., Liu, H.,
Jiang, R., Yamada, G. and Chen, Y. (2005). The cellular and
molecular etiology of the cleft secondary palate in Fgf10 mutant
mice. Dev. Biol. 277,102
-113.[CrossRef][Medline]
Bi, W., Deng, J. M., Zhang, Z., Behringer, R. R. and de
Crombrugghe, B. (1999). Sox9 is required for cartilage
formation. Nat. Genet.
22, 85.[CrossRef][Medline]
Blanton, S. H., Bertin, T., Serna, M., Stal, S., Mulliken, J. B.
and Hecht, J. T. (2004). Association of chromosomal regions
3p21.2, 10p13, and 16p13.3 with nonsyndromic cleft lip and palate.
Am. J. Med. Genet. 125A,23
-27.
Brugmann, S. A., Goodnough, L. H., Gregorieff, A., Leucht, P.,
ten Berge, D., Fuerer, C., Clevers, H., Nusse, R. and Helms, J. A.
(2007). Wnt signaling mediates regional specification in the
vertebrate face. Development
134,3283
-3295.[Abstract/Free Full Text]
Cadigan, K. M. and Nusse, R. (1997). Wnt
signaling: a common theme in animal development. Genes
Dev. 11,3286
-3305.[Free Full Text]
Carroll, T. J., Park, J.-S., Hayashi, S., Majumdar, A. and
McMahon, A. P. (2005). Wnt9b plays a central role in the
regulation of mesenchymal to epithelial transitions underlying organogenesis
of the mammalian urogenital system. Dev. Cell
9, 283-292.[CrossRef][Medline]
Ceccarelli, S., Cardinali, G., Aspite, N., Picardo, M.,
Marchese, C., Torrisi, M. R. and Mancini, P. (2007).
Cortactin involvement in the keratinocyte growth factor and fibroblast growth
factor 10 promotion of migration and cortical actin assembly in human
keratinocytes. Exp. Cell Res.
313, 1758.[CrossRef][Medline]
Chen, Y., Bei, M., Woo, I., Satokata, I. and Maas, R.
(1996). Msx1 controls inductive signaling in mammalian
tooth morphogenesis. Development
122,3035
-3044.[Abstract]
Dasgupta, R. and Fuchs, E. (1999). Multiple
roles for activated LEF/TCF transcription complexes during hair follicle
development and differentiation. Development
126,4557
-4568.[Abstract]
Ferguson, M. W. J. (1988). Palate development.
Development 103,41
-60.[Abstract/Free Full Text]
Gritli-Linde, A. (2007). Molecular control of
secondary palate development. Dev. Biol.
301, 309.[CrossRef][Medline]
Gu, S., Wei, N., Yu, X. Y., Jiang, Y., Fei, J. and Chen, Y.
P. (2008). Mice with an anterior cleft of the palate survive
neonatal lethality. Dev. Dyn.
237, 1509.[CrossRef][Medline]
Halford, M. M., Armes, J., Buchert, M., Meskenaite, V., Grail,
D., Hibbs, M. L., Wilks, A. F., Farlie, P. G., Newgreen, D. F., Hovens, C. M.
et al. (2000). Ryk-deficient mice exhibit craniofacial
defects associated with perturbed Eph receptor crosstalk. Nat.
Genet. 25,414
.[CrossRef][Medline]
Hilliard, S. A., Yu, L., Gu, S., Zhang, Z. and Chen, Y. P.
(2005). Regional regulation of palatal growth and patterning
along the anterior-posterior axis in mice. J. Anat.
207, 655.[Medline]
Hsieh, M., Boerboom, D., Shimada, M., Lo, Y., Parlow, A. F.,
Luhmann, U. F. O., Berger, W. and Richards, J. S. (2005).
Mice null for Frizzled4 (Fzd4-/-) are infertile and exhibit impaired corpora
lutea formation and function. Biol. Reprod.
73, 1135.[Abstract/Free Full Text]
Huelsken, J., Vogel, R., Erdmann, B., Cotsarelis, G. and
Birchmeier, W. (2001). β-catenin controls hair follicle
morphogenesis and stem cell differentiation in the skin.
Cell 105,533
-545.[CrossRef][Medline]
Jopling, C. and den Hertog, J. (2005). Fyn/Yes
and non-canonical Wnt signaling converge on RhoA in vertebrate gastrulation
cell movements. EMBO Rep.
6, 426.[CrossRef][Medline]
Keeble, T. R., Halford, M. M., Seaman, C., Kee, N., Macheda, M.,
Anderson, R. B., Stacker, S. A. and Cooper, H. M. (2006). The
Wnt receptor Ryk is required for Wnt5a-mediated axon guidance on the
contralateral side of the corpus callosum. J.
Neurosci. 26,5840
.[Abstract/Free Full Text]
Kilian, B., Mansukoski, H., Barbosa, F. C., Ulrich, F., Tada, M.
and Heisenberg, C. P. (2003). The role of Ppt/Wnt5a in
regulating cell shape and movement during zebrafish gastrulation.
Mech. Dev. 120,467
.[CrossRef][Medline]
Kim, H. J., Schleiffarth, J. R., Jessurun, J., Sumanas, S., Lin,
S. and Ekker, S. C. (2005). Wnt5a signaling in vertebrate
pancreas development. BMC Biol.
3, 23.[CrossRef][Medline]
Li, S. and Muneoka, K. (1999). Cell migration
and chick limb development: Chemotactic action of FGF4 and the AER.
Dev. Biol. 211,335
.[CrossRef][Medline]
Li, C., Xiao, J., Hormi, K., Borok, Z. and Minoo, P.
(2002). Wnt5a participates in distal lung morphogenesis.
Dev. Biol. 248,68
.[CrossRef][Medline]
Li, C., Hu, L., Xiao, J., Chen, H., Li, J. T., Bellusci, S.,
Delanghe, S. and Minoo, P. (2005). Wnt5a regulates Shh and
Fgf10 signaling during lung development. Dev. Biol.
287, 86-97.[CrossRef][Medline]
Liang, H., Chen, Q., Coles, A. H., Anderson, S. J., Pihan, G.,
Bradley, A., Gerstein, R., Jurecic, R. and Jones, S. N.
(2003). Wnt5a inhibits B cell proliferation and functions as a
tumor suppressor in hematopoietic tissue. Cancer Cell
4, 349-360.[CrossRef][Medline]
Lu, W., Yamamoto, V., Ortega, B. and Baltimore, D.
(2004). Mammalian Ryk is a Wnt coreceptor required for
stimulation of neurite outgrowth. Cell
119,97
-108.[CrossRef][Medline]
Martinez-Alvarez, C., Tudela, C., Perez-Miguelsanz, J., O'Kane,
S., Puerta, J. and Ferguson, M. W. J. (2000). Medial edge
epithelial cell fate during palatal fusion. Dev. Biol.
220,343
-357.[CrossRef][Medline]
Mikels, A. J. and Nusse, R. (2006). Purified
Wnt5a protein activates or inhibits beta-catenin/TCF signaling depending on
receptor context. PLoS Biol.
4, e115.[CrossRef][Medline]
Mlodzik, M. (2002). Planar cell polarization:
do the same mechanisms regulate Drosophila tissue polarity and vertebrate
gastrulation? Trends Genet.
18,564
-571.[CrossRef][Medline]
Moon, R. T., Campbell, R. M., Christian, J. L., McGrew, L. L.,
Shih, J. and Fraser, S. (1993). Xwnt-5A: a maternal Wnt that
affects morphogenetic movements after overexpression in embryos of Xenopus
laevis. Development
119,97
-111.[Abstract]
Mori-Akiyama, Y., Akiyama, H., Rowitch, D. H. and de
Crombrugghe, B. (2003). Sox9 is required for determination of
the chondrogenic cell lineage in the cranial neural crest. Proc.
Natl. Acad. Sci. USA 100,9360
-9365.[Abstract/Free Full Text]
Natanson-Yaron, S., Anteby, E. Y., Greenfield, C., Goldman-Wohl,
D., Hamani, Y., Hochner-Celnikier, D. and Yagel, S. (2007).
FGF10 and Sprouty 2 modulate trophoblast invasion and branching morphogenesis.
Mol. Hum. Reprod. 13,511
.[Abstract/Free Full Text]
Nawshad, A. and Hay, E. D. (2003). TGFβ3
signaling activates transcription of the LEF1 gene to induce epithelial
mesenchymal transformation during mouse palate development. J. Cell
Biol. 163,1291
.[Abstract/Free Full Text]
Niemann, S., Zhao, C., Pascu, F., Stahl, U., Aulepp, U.,
Niswander, L., Weber, J. and Muller, U. (2004). Homozygous
WNT3 mutation causes Tetra-Amelia in a large consanguineous family.
Am. J. Hum. Genet. 74,558
.[CrossRef][Medline]
Nishita, M., Yoo, S. K., Nomachi, A., Kani, S., Sougawa, N.,
Ohta, Y., Takada, S., Kikuchi, A. and Minami, Y. (2006).
Filopodia formation mediated by receptor tyrosine kinase Ror2 is required for
Wnt5a-induced cell migration. J. Cell Biol.
175, 555.[Abstract/Free Full Text]
Oishi, I., Suzuki, H., Onishi, N., Takada, R., Kani, S.,
Ohkawara, B., Koshida, I., Suzuki, K., Yamada, G., Schwabe, G. C. et al.
(2003). The receptor tyrosine kinase Ror2 is involved in
non-canonical Wnt5a/JNK signalling pathway. Genes
Cells 8,645
-654.[Abstract]
Okano, J., Suzuki, S. and Shiota, K. (2006).
Regional heterogeneity in the developing palate: morphological and molecular
evidence for normal and abnormal palatogenesis. Congenit.
Anom. 46,49
-54.[CrossRef]
Park, W. Y., Miranda, B., Lebeche, D., Hashimoto, G. and
Cardoso, W. V. (1998). FGF-10 is a chemotactic factor for
distal epithelial buds during lung development. Dev.
Biol. 201,125
.[CrossRef][Medline]
Rice, R., Spencer-Dene, B., Connor, E. C., Gritli-Linde, A.,
McMahon, A. P., Dickson, C., Thesleff, I. and Rice, D. P. C.
(2004). Disruption of Fgf10/Fgfr2b-coordinated
epithelial-mesenchymal interactions causes cleft palate. J. Clin.
Invest. 113,1692
.[CrossRef][Medline]
Roarty, K. and Serra, R. (2007). Wnt5a is
required for proper mammary gland development and TGF-β-mediated
inhibition of ductal growth. Development
134,3929
-3939.[Abstract/Free Full Text]
Sakaguchi, S., Nakatani, Y., Takamatsu, N., Hori, H., Kawakami,
A., Inohaya, K. and Kudo, A. (2006). Medaka unextended-fin
mutants suggest a role for Hox8c in cell migration and osteoblast
differentiation during appendage formation. Dev. Biol.
293, 426.[CrossRef][Medline]
Schambony, A. and Wedlich, D. (2007).
Wnt-5A/Ror2 regulate expression of XPAPC through an alternative noncanonical
signaling pathway. Dev. Cell
12,779
-792.[CrossRef][Medline]
Schwabe, G. C., Trepczik, B., Suring, K., Brieske, N., Tucker,
A. S., Sharpe, P. T., Minami, Y. and Mundlos, S. (2004). Ror2
knockout mouse as a model for the developmental pathology of autosomal
recessive Robinow syndrome. Dev. Dyn.
229, 400.[CrossRef][Medline]
Takeuchi, S., Takeda, K., Oishi, I., Nomi, M., Ikeya, M., Itoh,
K., Tamura, S., Ueda, T., Hatta, T., Otani, H. et al. (2000).
Mouse Ror2 receptor tyrosine kinase is required for the heart development and
limb formation. Genes Cells
5, 71-78.[Abstract]
Taya, Y., Okane, S. and Ferguson, M. W. J.
(1999). Pathogenesis of cleft palate in TGF-β3 knockout
mice. Development 126,3869
-3879.[Abstract]
Topol, L., Jiang, X., Choi, H., Garrett-Beal, L., Carolan, P. J.
and Yang, Y. (2003). Wnt-5a inhibits the canonical Wnt
pathway by promoting GSK-3-independent {beta}-catenin degradation.
J. Cell Biol. 162,899
.[Abstract/Free Full Text]
Torres, M. A., Yang-Snyder, J. A., Purcell, S. M., DeMarais, A.
A., McGrew, L. L. and Moon, R. T. (1996). Activities of the
Wnt-1 class of secreted signaling factors are antagonized by the Wnt-5A class
and by a dominant negative cadherin in early Xenopus development.
J. Cell Biol. 133,1123
.[Abstract/Free Full Text]
Tudela, C., Formoso, M.-A., Martínez, T., Pérez,
R., Aparicio, M., Maestro, C., Río, A. D., Martínez, E.,
Ferguson, M. W. and Martínez-Alvarez, C. (2002).
TGF-β3 is required for the adhesion and intercalation of medial edge
epithelial cells during palate fusion. Int. J. Dev.
Biol. 46,333
.[Medline]
Veeman, M. T., Axelrod, J. D. and Moon, R. T.
(2003). A second canon: functions and mechanisms of
β-catenin-independent Wnt signaling. Dev. Cell
5, 367-377.[CrossRef][Medline]
Weeraratna, A. T., Jiang, Y., Hostetter, G., Rosenblatt, K.,
Duray, P., Bittner, M. and Trent, J. M. (2002). Wnt5a
signaling directly affects cell motility and invasion of metastatic melanoma.
Cancer Cell 3,279
-288.
Witze, E., Litman, E. S., Argast, G. M., Moon, R. T. and Ahn, N.
G. (2008). Wnt5a control of cell polarity and directional
movement by polarized redistribution of adhesion receptors.
Science 320,365
-369.[Abstract/Free Full Text]
Yamaguchi, T. P., Bradley, A., McMahon, A. P. and Jones, S.
(1999). A Wnt5a pathway underlies outgrowth of multiple
structures in the vertebrate embryo. Development
126,1211
-1223.[Abstract]
Yamamoto, H., Yoo, S. K., Nishita, M., Kikuchi, A. and Minami,
Y. (2007). Wnt5a modulates glycogen synthase kinase 3 to
induce phosphorylation of receptor tyrosine kinase Ror2. Genes
Cells 12,1215
-1223.[Abstract/Free Full Text]
Yu, L., Gu, S., Alappat, S., Song, Y., Yan, M., Zhang, X.,
Zhang, G., Jiang, Y., Zhang, Z., Zhang, Y. and Chen, Y. P.
(2005). Shox2-deficient mice exhibit a rare type of
incomplete clefting of the secondary palate.
Development 132,4397
-4406.[Abstract/Free Full Text]
Zhang, Z., Song, Y., Zhao, X., Zhang, X., Fermin, C. and Chen,
Y. P. (2002). Rescue of cleft palate in
Msx1-deficient mice by transgenic Bmp4 reveals a network of
BMP and Shh signaling in the regulation of mammalian palatogenesis.
Development 129,4135
-4146.[Abstract/Free Full Text]

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
E. K. Vladar, D. Antic, and J. D. Axelrod
Planar Cell Polarity Signaling: The Developing Cell's Compass
Cold Spring Harb Perspect Biol,
September 1, 2009;
1(3):
a002964 - a002964.
[Abstract]
[Full Text]
[PDF]
|
 |
|